SCHEMBL794268

SCHEMBL794268

Cc1cccc(NC(=O)N2CCN(c3nc(C(=O)O)nc4sc(-c5ccc(F)cc5)cc34)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.50
FAAH O00519 4/20 0.49
PI4KB Q9UBF8 1/20 0.49
RAB9A P51151 2/20 0.45
MAPT P10636 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
LIMK2 P53671 1/20 0.45
ALDH1A1 P00352 3/20 0.44
P2RY12 Q9H244 2/20 0.44
FLT4 P35916 1/20 0.44
BTK Q06187 1/20 0.44
MELK Q14680 1/20 0.44
MINK1 Q8N4C8 1/20 0.44
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
CNR1 P21554 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654080 0.93 PI4KB (0.50) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL655023 0.90 P2RY12 (0.55) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL656042 0.89 FAAH (0.57) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL653429 0.89 PI4KB (0.62) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL1720316 0.86 P2RY12 (0.51) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL18035918 0.84 P2RY12 (0.48) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL652536 0.83 PI4KB (0.65) CNR2FAAHPI4KBRAB9AMAPT
SCHEMBL1720987 0.78 PI4KB (0.59) CNR2FAAHPI4KBGPR55ALDH1A1
SCHEMBL4362142 0.78 PI4KB (0.58) FAAHPI4KBRAB9AMAPTLIMK2
SCHEMBL4365747 0.76 FAAH (0.49) FAAHPI4KBRAB9AMAPTLIMK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-B1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES UNIV LEUVEN KATH (BE) 2016-08-31 EP claimed
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP claimed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO claimed